Hora Maninder 4
4 · NEKTAR THERAPEUTICS · Filed Dec 19, 2017
Insider Transaction Report
Form 4
Hora Maninder
SVP Pharma Dev and Mfg
Transactions
- Award
Stock Option
2017-12-15+37,500→ 37,500 totalExercise: $56.90Exp: 2025-12-14→ Common Stock (37,500 underlying) - Award
Common Stock
2017-12-15+15,000→ 83,136 total
Footnotes (3)
- [F1]This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. These RSUs vest over three years in substantially equal quarterly installments based on continued service.
- [F2]This number includes 6,500 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c).
- [F3]This stock option vests over four years in equal monthly installments based on continued service.